This free script provided by
JavaScript Kit


Catalog #:

IN0071-1mg USD162.0
IN0071-5mg USD630.0

References for Ryanodine:

1. Amador, F. J., Liu, S., Ishiyama, N., Plevin, M. J., Wilson, A., MacLennan, D. H., and Ikura, M. Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop. Proc Natl Acad Sci U S A, 106: 11040-11044, 2009.

2. Saldana, C., Diaz-Munoz, M., Antaramian, A., Gonzalez-Gallardo, A., Garcia-Solis, P., and Morales-Tlalpan, V. MCF-7 breast carcinoma cells express ryanodine receptor type 1: functional characterization and subcellular localization. Mol Cell Biochem, 323: 39-47, 2009.

3. Abdul, M., Ramlal, S., and Hoosein, N. Ryanodine receptor expression correlates with tumor grade in breast cancer. Pathol Oncol Res, 14: 157-160, 2008.

4. Newmark, J. L., Voelkel, M., Brandom, B. W., and Wu, J. Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient. Anesthesiology, 107: 350-353, 2007.

5. Cui, L. Y., Li, Y. F., Li, Y. H., and Zhang, J. B. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 29: 238-240, 2007.

6. Hashii, M., Shuto, S., Fukuoka, M., Kudoh, T., Matsuda, A., and Higashida, H. Amplification of depolarization-induced and ryanodine-sensitive cytosolic Ca2+ elevation by synthetic carbocyclic analogs of cyclic ADP-ribose and their antagonistic effects in NG108-15 neuronal cells. J Neurochem, 94: 316-323, 2005.

Certificate of Analysis/MSDS is available upon request with lot number

Home | Contact | Support | Privacy Policy, Terms Warranty | Apycom jQuery Menus